Magalhães D, Cabral JM, Soares-Da-Silva P, Magro F. Role of epithelial ion transports in inflammatory bowel disease. Am J Physiol Gastrointest Liver Physiol 310: G460 -G476, 2016. First published January 7, 2016; doi:10.1152/ajpgi.00369.2015.-Inflammatory bowel disease (IBD) is a chronic inflammatory disorder with a complex pathogenesis. Diarrhea is a highly prevalent and often debilitating symptom of IBD patients that results, at least in part, from an intestinal hydroelectrolytic imbalance. Evidence suggests that reduced electrolyte absorption is more relevant than increased secretion to this disequilibrium. This systematic review analyses and integrates the current evidence on the roles of epithelial Na ϩ -K ϩ -ATPase (NKA), Na ϩ /H ϩ exchangers (NHEs), epithelial Na ϩ channels (ENaC), and K ϩ channels (KC) in IBD-associated diarrhea. NKA is the key driving force of the transepithelial ionic transport and its activity is decreased in IBD. In addition, the downregulation of apical NHE and ENaC and the upregulation of apical large-conductance KC all contribute to the IBDassociated diarrhea by lowering sodium absorption and/or increasing potassium secretion.
inflammatory bowel disease; K ϩ channels; Na ϩ -K ϩ -ATPase; Na ϩ /H ϩ exchangers; epithelial Na ϩ channels INFLAMMATORY BOWEL DISEASE (IBD) is a chronic inflammatory disorder that comprises Crohn's disease (CD) and ulcerative colitis (UC), whose pathogenesis is thought to be a complex mixture of genetic, intestinal microbiome, immune response, and environmental factors that result in an excessive and abnormal immune response against commensal flora (141) . Clinically, diarrhea is a highly prevalent and often debilitating symptom in IBD patients. Although there are plenty of causes for diarrhea in IBD (such as malabsorption, infections, or iatrogenic), the effects of inflammation on ion intestinal transport and smooth muscle tone are the most important ones (142) . The effectors are endogenous inflammatory mediators found in high concentrations in CD and/or UC, such as TNF-␣, IL-1␤, IL-6, IFN-␥, monochloramine (NH 2 Cl), and nitric oxide (NO), and also pathogen-associated molecular patterns from gut microbiota (12, 19, 26, 32, 104, 124) . Thus a comprehensive understanding of the epithelial hydroelectrolytic disequilibrium is of utmost relevance to develop better treatments. In both UC and CD, lower sodium and water net absorption, rather than increased anion secretion, seems to be the major mechanism of watery stools (54, 114) . This review focuses on Na ϩ -K ϩ -ATPase (NKA), Na ϩ /H ϩ exchangers (NHEs), epithelial Na ϩ channels (ENaC), and K ϩ channels (KC) in intestinal tract (IT) epithelial cells from IBD patients, experimental colitis models, or healthy epithelia exposed to proinflammatory mediators. After a summary of the physiological role of NKA, NHE, ENaC, and KC in healthy intestinal epithelia, their relevance in IBD will be described, namely on a low-sodium absorption model that helps explain diarrhea in inflammatory bowel disease. Tables 1-5 and 7 Of these, 88 were excluded based on abstract for not specifically studying the targeted ion transporters and 4 because of full text unavailability. The remaining 92 articles were fully read to assess for eligibility, as well as 13 potentially relevant papers found in the reference list of the retrieved reports. Thirty-seven articles were excluded owing to focusing on immune or nonepithelial cells, or not referring to IBD, experimental colitis models, or IBD-associated proinflammatory factors in IT epithelial cells.
HEALTHY INTESTINAL TRACT EPITHELIUM
NKA is a primary active transporter of 3 Na ϩ outward and 2 K ϩ inward located in the basolateral membrane (BLM) of all epithelial cells (127) . It integrates an ␣-subunit, responsible for ion movement and various binding sites, and a ␤-subunit, required for the correct enzyme assembly and membrane targeting. Four ␣-isoforms and two ␤-isoforms have been identified: ␣ 1 is ubiquitously expressed, ␣ 2 and ␣ 3 are found in skeletal muscle, neurons, and cardiomyocytes, and ␣ 4 is expressed in testis (149) . Besides ion transport function, NKA is a receptor for endogenous cardiotonic steroids (such as ouabain) that trigger several intracellular signal pathways while blocking the ionic transport (149) . NKA maintains chemical and electrical gradient between intra-and extracellular spaces, allowing the movement of several ions, most importantly Na Ϫ . This is particularly noteworthy in the IT, where ϳ9 liters of water and 800 mg of Na ϩ are processed every day based on transepithelial ionic differences (137) .
There is a wealth of evidence that epithelial intestinal NKA activity is reduced in IBD and experimental models of colitis, though whether this results from lower expression is more controversial (see Tables 1 and 2 -5) are located in the plasma membrane (PM); NHE6-9 (SLC9A6-9) are intracellular isoforms, existing along the secretory and endocytic pathways; NHA1-2 (SLC9B1-2) location and functions are still majorly unknown; SLC9C1 is sperm specific; and SLC9C2 is a putative NHE (46) . NHE1 is expressed in the epithelial BLM of every IT segment (160) . It has housekeeping activities, working as a major cellular alkalinizing mechanism and restoring cell volume after cell shrinkage, by allowing Na ϩ to flux in and extruding H ϩ (46) . Changes in NHE1 activity and expression in IBD are still uncertain, with both increased and decreased expression having been reported (Tables 3 and 4) . CD, Crohn's disease; HETEs, hydroxytetraenoic acids; IBD, inflammatory bowel disease; IHC, immunohistochemistry; Isc, short-circuit current; IT, intestinal tract; LTB4, leukotriene B4; N/A, not available; NB, Northern blotting; NKA, Na ϩ -K ϩ -ATPase; PGE2, prostaglandin E2; R, row; T, Table; TNFR-1, TNF receptor-1; UC, ulcerative colitis; WB, Western blotting; WB-MP, Western blotting of membrane proteins; WB-TP, Western blotting of total cell proteins.
NHE2 and NHE3 are present in the epithelial brush-border membrane throughout the human IT (59) . Active NHE2 is exclusively located in the PM, whereas active NHE3 cycles between PM and endosomes (34) . Although NHE3 is the major absorptive NHE in most mammalian species studied [such as mice (120) ], both participate in intestinal Na ϩ absorption and their relative contribution appears to be species and intestinal segment dependent (160) . A detailed description of the regulation of NHE3 is beyond the scope of this review, but a brief explanation is provided because of its relevance to IBDassociated diarrhea.
The NHERF (NHE regulatory factor) family, which consists of NHERF1, NHERF2/E3KARP, NHERF3/PDZK1, and NH-ERF4/IKEPP, regulates NHE3 cytoskeletal transport, apical expression, and basal activity (79) . NHERF1 Ϫ/Ϫ mice featured reduced jejunal fluid absorption in vivo, as well as attenuated in vitro Na ϩ absorption in isolated jejunal and colonic, but not ileal, mucosa. Moreover, NHE3 activity and membrane expression were reduced, although mRNA levels were not affected (21) . One study found NHERF2 Ϫ/Ϫ mice to have lower ileal NHE3 activity due to impaired trafficking or retention of NHE3 in the apical membrane (99) , which is possibly related to NHERF2 association with lipid-raft NHE3 (136) . In fact, lysophosphatidic acid (LPA, released in inflammatory settings to repair wounded tissue) stimulates NHE3 activity and expression through NHERF2-dependent mechanisms in ileum (99) and kidney brush border (27, 84). In contrast, Chen et al.
(28) observed normal NHE3 mRNA and membrane expres- sion but increased basal fluid absorption rates in the ileum of NHERF2 Ϫ/Ϫ mice, which could be attributed to a higher fraction of exchangers in the microvillar tip compared with the terminal region of the microvilli. Conflicting results aside, it is clear that NHERF2 is important for NHE3 regulation in IT, including cGMP-and Ca 2ϩ -dependent NHE3 inhibition (99) . In turn, PDZK1 is required for cAMP-and Ca 2ϩ -dependent NHE3 inhibition (30), and its deletion in rodents results in decreased colonic and jejunal electroneutral sodium absorption (30, 57). NHE2/3 and the NHERF family are important pieces in the pathophysiological puzzle of IBD-associated diarrhea, and as such their roles are presented in Tables 3 and 4. NHE4 is a poorly studied antiporter expressed in healthy human and rat colonic crypts, where, akin to NHE1, it functions as a basolateral intracellular pH regulator (9, 16) . NHE5 and NHE6 do not seem to be present in the human small intestine or colon (160) . NHE7 (in trans-Golgi network) and NHE9 (in recycling endosomes) are widely spread exchangers whose physiological functions are still poorly understood (46) . Finally, NHE8 is a recently discovered ubiquitous endosomal and Golgi-network NHE, with apical expression in renal proximal tubules (46) . It is expressed along the entire human IT, with higher levels being detected in jejunum and colon, but its intestinal epithelial apical membrane expression has only been evaluated in rodents (151, 152) . NHE8 is thought to be a major route for small intestine Na ϩ absorption in rodent neonates, being largely substituted by NHE2 and NHE3 later in life (151, 152) . However, NHE8
Ϫ/Ϫ mice displayed normal Na ϩ serum levels and no signs of diarrhea, which could be attributed to the compensatory upregulation of NHE2 and NHE3 in the small intestine of those mice (153) . Their distal colons featured decreased Muc2 gene expression, disorganized mucin layers, high proinflammatory cytokine expression (IL-4), and increased bacterial adhesion (89) . Given the aforementioned apparent absorptive and inflammatory involvement, as well as its interactions with TNF-␣, TNBS (trinitrobenzenesulfonic acid), and lipopolysaccharide (LPS) ( Tables 3 and 4) , NHE8 presents as a promising research topic in IBD (150). Inflamed tissues feature normal NHE3 and NHERF1 expression and location but lower NHE activity and also strongly reduced PDZK1 mRNA and protein expression (see T4 R16).
*Isoform not specified. AC3, adenyl cyclase 3; IEC, intestinal epithelial cells; qPCR, quantitative real-time polymerase chain reaction; PI3K, phosphatidylinositol 3-kinase; PKA, protein kinase A; PKC, protein kinase C; PLC, phospholipase C; RT-PCR, reverse transcription polymerase chain reaction; RT-qPCR, reverse transcription qPCR; SCR, tyrosine-protein kinase; Sp1/3, transcription factor; TLR2/4/5, toll-like receptor 2/4/5; UC, ulcerative colitis. 
Epithelial Na ϩ channels
ENaCs are heterotrimeric channels formed by ␣-, ␤-, and ␥-subunits that mediate an electrogenic, passive, and selective Na ϩ absorption in the apical membrane of several epithelia. They are sensitive to the inhibitor amiloride, while being upregulated by aldosterone and glucocorticoids (67) . In the IT, ENaCs are expressed in the distal colon and rectum, where they are the most important route for sodium absorption (43) . Similar to what happens to NHE3, ENaC activity is downregulated in IBD (Table 5) ; this contributes to the low-sodium absorption state that characterizes IBD-associated diarrhea (see Fig. 1 ).
K ϩ Channels
The KCs transport K ϩ in and out of excitable and nonexcitable cells. Because of differences in structure and function, they are grouped in voltage-gated (K v ), inwardly rectifying (K ir ), tandem pore domain (K2P), and ligandgated (K ligand ) classes (77) . Irrespective of the class, KCs are composed by a pore-forming domain and a regulatory domain (77) . Table 6 summarizes the nomenclature and composition of the channels referred in this article; their roles in the healthy intestinal epithelium are presented here, whereas their changes in IBD and experimental colitis are referred in Table 7 . (62) .
BK channels (formed by ␣-subunits and ␤-subunits) are expressed in the apical membrane of rat colonocytes, mainly in the crypts (131), where they secrete K ϩ into the lumen (23, 66). In human colonic mucosa, apical BK channels are also responsible for K ϩ secretion [which is induced by cAMP (117)] but are located exclusively in goblet cells (88) . An earlier study had reported an expression only in surface cells and cells in the upper 20% of the crypt axis and had found that they are mainly composed of ␤ 1 and ␤ 3 subunits (116). Briefly, apical BK channels appear to be upregulated in IBD and colitis models (66, 83, 116) , which may contribute to higher potassium concentrations in the IT lumen and consequently to watery stools (Table 7) .
Immunohistochemical staining of human colonic biopsies revealed SK1 channels in the neurons of myenteric and submucosal colonic plexi, SK3 in the visceral and vascular smooth muscle, and IK in inflammatory cells, epithelial cells, and myenteric and submucosal plexi (29). SK3 and IK mRNA, but not SK1 or SK2 mRNA, were detected in the small intestine and rectum (29).
IK channels perform noteworthy functions in the intestinal epithelium. They are the dominant basolateral K ϩ channels in human colonocytes (but not in goblet cells) and are expressed throughout the length of crypt axis (2, 88) . In fact, they are required for the cAMP-stimulated Cl Ϫ secretion through CFTR (cystic fibrosis transmembrane conductance regulator), which is independent of BK channel activation (117) . IK are also found in colonocytes of healthy rats, validating this species as a study model (132) . In the human small intestine mucosa they are expressed in Paneth cells (128) , probably contributing to the release of antimicrobial peptides (10), and intraepithelial leukocytes (128) , where they participate in proinflammatory processes. In fact IK are, alongside K v 1.3 (73) , crucial for T cell activation and proliferation: they keep an electrical gradient that allows Ca 2ϩ influx, which is a required step for the translocation of the nuclear factor of activated T cells (NFAT) to the nucleus, ultimately resulting in cytokine secretion and T cell proliferation (20, 62) . Given that IBD is a T cell-driven disease, it is unsurprising that inhibition of lymphocytic IK channels reduces inflammation and colitis manifestations, and therefore IK blockade has received considerable attention as a potential therapeutic target (38, 53, 106, 132 
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Ϫ/Ϫ mice) (38) . In contrast, few studies have addressed the role of IK in intestinal epithelial cells (IEC) in IBD; nevertheless, their function seems to be downregulated (Table 7) (2, 58).
K ATP channels. K ATP channels are inwardly rectifying ATPmodulated channels formed by four K ir 6.x and four SURx subunits that open with a decrease in intracellular ATP (56) . Sulfonylureas (such as tolbutamide and glibenclamide) block these channels, whereas pinacidil and nicorandil are channel openers, and both act on the SUR subunit. K ATP channels drive the resting membrane potential closer to the equilibrium potential of K ϩ (around Ϫ97 mV), hyperpolarizing cells and relaxing IT myocytes (56) . Thus they have been implicated in colonic hypomotility observed in IBD-like animal models. In the mouse colon (where channels are formed by K ir 6.1 and SUR2B subunits), they are more activated in inflamed myocytes than in controls (K ir 6.1 mRNA increased 22-fold, whereas SUR2B is decreased) (1, 63) . In lymphatic vessels of TNBS-inflamed guinea pig ileum, NO stimulates the cGMP/ PKG pathway, upregulating mRNA level and activity of K ATP channels, which impairs lymphatic pumping (96) . On the other hand, hydrogen sulfide (H 2 S) beneficial effects on colitis severity and mortality have been attributed to the activation of K ATP channels through S-sulfhydration of the SUR2B subunit (47, 65, 140) . K ATP channels are present in the basolateral membrane of the rat colonocytes, but their exact composition is still unknown (109) . In humans, the Kir6.1-SUR2A protein pair has been described in the small intestine epithelium (64) . However, despite their presumable importance, functions of K ATP channels have not been assessed yet in disease-afflicted human IECs; nonetheless, their tissue-unspecific inhibition with glibenclamide worsened colitis ( Table 7) .
CROSS TALK BETWEEN NA
؉ -K ؉ -ATPASE, NA ؉ /H ؉
EXCHANGERS, EPITHELIAL NA ؉ CHANNELS, AND K
؉
CHANNELS IN THE INFLAMED INTESTINAL TRACT EPITHELIUM
Diarrhea is a common symptom in IBD, resulting from hydroelectrolytic imbalance (142) . However, the multitude of ion transporters, cell types, and inflammatory factors involved, as well as species and IT section differences in study models, turn the elaboration of a comprehensive pathophysiological molecular model into an elusive task. Here we analyze the altered activity and mutual influence of four ion transporter classes in the inflamed IT epithelium, merging their contributions into a low-sodium absorption model that helps to explain watery stools in IBD (Fig. 1) .
Downregulation of Na
Being the fundamental driving force of transepithelial ionic transport, it is likely that low NKA activity (and expression) observed in most IBD studies and colitis models may have a major influence in the IT water balance (Tables 1 and 2 ). Three proinflammatory cytokines are known to downregulate NKA: IFN-␥, TNF-␣, and IL-1␤. T cell-produced IFN-␥ (18, 93, 134) is thought to activate the PKC downstream STAT1 phosphorylation and Raf-1, MEK, ERK2, and p38 MAPK (92), but there is conflicting evidence regarding its dependency of NO (134, 158) . TNF-␣ decreases the NKA activity possibly through PGE 2 (95, 100) and to a smaller extent also lowers the expression of the Na/K/Cl symporter (95), whereas IL-1␤ downregulates NKA but stimulates Na/K/Cl symporter (and thus Cl Ϫ secretion) (76) . Lipoxygenase products (HETEs and LTB 4 ) did not affect colonic NKA activity (3), whereas TGF-␤ and NH 2 Cl increased it (93, 121) . NO, found in high concentrations in IBD (19) , also inhibits NKA activity in T84 cells (134) . Acute exposure to LPS [a component of gram-negative bacteria implicated in the pathogenesis of IBD (26)] reduces NKA in renal tubule epithelium, apparently owing to increased iNOS activity and excessive production of reactive nitrogen species (98, 119, 123) . Finally, a recent study in rabbit chronically inflamed small intestine found decreased NKA expression in the BLM as a result of downregulation and depolarization of ankyrin protein expression (113) .
The most important consequence of reduced NKA activity is the accumulation of intracellular Na ϩ that, coupled with reduced ENaC (more relevant in human distal colon) (5, 43, 161) and NHE (more relevant in human proximal colon) (5, 43, 135) expression in IBD, diminishes Na ϩ absorption (Fig. 1) . It also increases cell volume, which lowers the expression of Na/K/Cl cotransporter and occludins, influencing Cl Ϫ secretion and tight junction permeability (134) .
Role of Epithelial K ϩ Channels
The third consequence of low NKA activity [i.e., higher intracellular Na
] is a slight cell depolarization, which adds to the greater depolarization prompted by the decreased BLM IK channels activity reported in UC and dextran sulfate sodium (DSS)-treated mice (Table 7) (2, 58) . This has two consequences: first, it further lessens electrogenic Na ϩ uptake in ENaC-rich IT zones (2); second, because BLM IK channels transport less K ϩ , it escapes through the upregulated apical BK channels and contributes to diarrhea (Fig. 1)  (66, 116) . Sandle et al. (116) found that BK channels spread through the entire crypt axis in UC, instead of being limited to the upper 20% of the axis. Aldosterone may have a role in this. In fact, it enhances colonic apical BK and IK channel expression and secretion (129) , and its serum concentrations were increased in DSS mice (probably as an attempt to increase ENaC-mediated absorption due to excessive sodium fecal losses) (66) . Another potential upregulating factor is NO (66), whether through direct channel nitrosylation (80) or via PKG (protein kinase G) (45) .
Therefore, higher luminal levels of Na ϩ (due to lower absorption; see the NHE3 and ENaC sections below) and K ϩ (due to increased secretion) may contribute to watery stools in IBD. Besides, high K ϩ secretion could explain hypokalemia observed in severe cases of UC (116) . Epithelial K ATP channels, as abovementioned, have not been specifically studied yet, but glibenclamide worsens colitis (35, 42) and nicorandil has been proposed for the management of IBD (60) . Interestingly, monochloramine (NH 2 Cl) increased basolateral Ca 2ϩ -dependent K ϩ conductance and NKA activity in healthy rat colonic epithelia and T84 cells, suggesting that it may contribute to diarrhea in IBD due to increased anion secretion rather than low sodium absorption (121, 133) .
Role of NHE1 in IBD Is an Unsettled Question
Fitting NHE1 in the pathophysiology of IBD is not a straightforward task (Fig. 1) . On one hand, several studies have reported decreased mucosal NHE1 mRNA and protein expression in UC and CD (71, 126, 135) , with upregulated TLR4/ MyD88/NF-B pathway being pointed as a suppressive mechanism (126) (see Tables 3 and 4) . Subsequently, studies in T84 intestinal cells described that stimulation of TLR2 (activated by lipoteichoic acid) (25), TLR4 (activated by monophosphoryl lipid A, a LPS derivative), and TLR5 (activated by flagellin) (24) all inhibited NHE1, although independently of NF-B (25) (Fig. 1) . Furthermore, IFN-␥ inhibits NHE1 activity (albeit not expression) in the human intestinal Caco-2 cell line through a signaling pathway that includes Raf-1, MEK, p38, and PKC activation (at short term) and STAT1 phosphorylation (at long term) (94) .
In contrast, other studies described upregulation of NHE1 throughout the colon in UC patients (43) and colitis-afflicted rats (68) . NHE1 exist in many cell types and are known to participate in inflammatory processes. In fact, NHE1 inhibition 1) protects multiple organs from ischemia-reperfusion injury by inhibiting NF-B activation and consequently reducing iNOS expression, neutrophil infiltration, IL-6 production, and ERK1/2 phosphorylation (146, 147); 2) attenuates leukocyteendothelial cell interaction (22, 111); 3) improves hemodynamic performance and decreases plasma levels of proinflammatory cytokines (TNF-␣, IL-6, IL-8) in septic rats and pigs with metabolic acidosis (87, 145) ; and 4) reduces LPS-induced secretion of IL-1␤ and TNF-␣ in the alveolar epithelium by halting the phosphorylation of IB-␣, which accumulates in the cytoplasm and blocks the DNA-binding activity of NF-B (52) .
The effects of NHE1 inhibition in intestinal inflammatory conditions also point to a proinflammatory role. Amiloride [a nonspecific NHE inhibitor to which NHE1 and 2 are very sensitive, in contrast with NHE3 and 4 (36)] reversed some colitis manifestations in TNBS-treated rats, recovered contractility, and restored normal NKA activity in colonic smooth muscle cells through decreased IL-1␤ and ERK activation (70) . Furthermore, amiloride and other compounds prevented the release of IL-8 (a proinflammatory mediator) by IEC through decreased NF-B and ERK1/2 activation and attenuated disease activity in DSS-treated mice (103) as well as in lithium (a NHE stimulator)-induced IT inflammation (102) . Finally, burns cause the release of IFN-␥, TNF-␣, and IL-1␤ in the IT, starting an inflammatory process that damages the mucosa; cariporide (a specific NHE1 inhibitor) reduces burn-induced NF-B and p38 MAPK activation in IT (155) and hinders local and systemic inflammatory responses (154) .
Despite these results, it should be noted that 1) most studies did not specifically address epithelial NHE1; 1) the effects of amiloride may be ascribed to NHEs other than NHE1; and 2) the inhibition of the antiporters in intraepithelial leukocytes may account for the decreased inflammatory state. Besides, the several reports of reduced NHE1 activity (Tables 3 and 4) are consistent with IBD colonocytes having low intracellular pH (112a), since a lower antiporter transfer rate would leave more H ϩ inside. In any case, it is clear that further studies are required to settle this question.
NHE3 Is Impaired in IBD
In contrast to NHE1, there is substantial agreement that NHE3 function is compromised in IBD and experimental models of colitis (see Tables 3 and 4 and Fig. 1) . A direct implication of this decrease in NHE3 activity is a lower Na ϩ absorption [with highest impact in the proximal colon, where electroneutral NaCl uptake is more relevant (122) ], which in turn contributes to the IBD-associated diarrhea (21, 43, 135, 156) . Some studies reported both lowered activity and expression of NHE3 (13, 125, 135) , whereas others have observed reduced NHE3 activity associated with no changes in expression (43, 85, 156, 157) .
Why is NHE3 affected in IBD? Once again proinflammatory cytokines are partially to blame. IFN-␥ and TNF-␣ (but not IL-1␤) decrease NHE3 activity and mRNA expression (7, 112, 125) . This reduction may result from cAMP-dependent PKAmediated phosphorylation of Sp1 and Sp3 (transcription factors), which decreases their affinity for the gene promoter region (7) . Furthermore, TNF-␣ internalizes NHE3 through a PKC␣-dependent mechanism (31). The functionwise closely related NHE2 and NHE8 isoforms are also downregulated by TNF-␣, either by a pathway involving Sp3 (NHE8) (150) , through NF-B activation (NHE2) (8) , or through impaired trafficking to the apical membrane (NHE2) (78) due to TNF-␣-induced IEC galectin-3 mRNA downregulation in IBD (61) . Finally, IFN-␥ may also indirectly reduce NHE expression by downregulating NKA activity and therefore increasing [Na ϩ ] i (134) .
The NHERF family members, which are important in NHE3 cytoskeletal transport, apical expression, and basal activity (see HEALTHY INTESTINAL TRACT EPITHELIUM above), are another hot topic of research. One study found NHERF1/2 proteins to be downregulated in the sigmoid mucosa of UC and CD and in the ileal mucosa of CD (125), whereas Yeruva et al. (156) reported normal NHE3 and NHERF1 expression and localization, but lower NHE3 activity and strongly reduced PDZK1 mRNA and protein expression in inflamed human and murine enterocytes. Similarly, in enterocytes of IL-10 Ϫ/Ϫ mice (a model of IBD), NHE3 and NHERF1 expression and localization were unchanged but NHE3 was dysfunctional, which was associated with a downregulation of NHERF2 and PDZK1 (85) . Hence, the available evidence suggests that downregulation of NHERF reduces NHE3 activity in IBD. In contrast to NHE1 (see Role of NHE1 in IBD Is an Unsettled Question above), activation of TLR4 and TLR5 influenced NHE3 activity in opposite ways, though this surely deserves more research (24). Lastly, nitric oxide decreases NHE3 (but not NHE2) activity in Caco-2 cells through the guanylate cyclase/cGMP/PKG pathway (48) , which is consistent with disease attenuation in experimental models of chronic colitis due to inhibition of NO synthase (74) (Fig. 1) .
Interestingly, NHE3 relevance in IBD is not restricted to fluid controlling; it appears to be important in altering cytokine release and influence IT microbiota. NHE3 Ϫ/Ϫ mice develop spontaneous distal colitis characterized by diarrhea, rectal prolapse, reduced body weight, histological inflammatory signs, and higher levels of inducible NO synthase, TNF-␣, macrophage inflammatory protein-2 (MIP-2), and IL-18 (83) . Knocking out NHE3 in IL-10 Ϫ/Ϫ mice also resulted in higher levels of chemokines (MIP-2, CXCL1, CXCL10, and CXCL11), IFN-␥, IL-17, and IL-12/23 p40, as well as increased IEC apoptosis (82) . Surprisingly, the major inflammation trigger in NHE3 Ϫ/Ϫ mice was the increased bacterial adhesion and translocation, since antibiotic treatment reversed many colitis manifestations (83) . Later studies on the colonic microbiota of NHE3 Ϫ/Ϫ mice found increased Bacteroidetes but decreased Firmicutes bacteria (40) and overall lower bacterial diversity (81) , which goes along with reports of reduced and altered microbiota in patients with IBD (107) . Curiously, NHE2 Ϫ/Ϫ mice (which are not a model of IBD) featured radically different microbiota changes (41) .
In conclusion, several factors appear to be involved in NHE3 downregulation in IBD (Fig. 1) . This not only contributes to watery stools due to reduced Na ϩ absorption but also appears to affect gut microflora and cytokine production.
Epithelial Na
ϩ Channels' Activity Is Decreased in IBD ENaC-mediated sodium transport, most important in the distal colon and rectum, is impaired in both IBD-afflicted colon (43, 49, 50, 115) and experimental colitis models (JAK3 Ϫ/Ϫ or IL-2 Ϫ/Ϫ mice) (13, 14, 139) (see Table 5 ). TNF-␣ and IFN-␥ are once more involved in this downregulation: they both reduce ␤-and ␥-subunit ENaC gene expressions in UC (5), and TNF-␣ reduces ␥-subunit transcription even in macroscopically noninflamed colon in CD (161) . Furthermore, IFN-␥ impairs EGFR (epidermal growth factor receptor) activation by reducing phosphorylation of specific EGFR tyrosine residues (108). This is relevant since EGFR ligands (such as EGF and TGF-␣), whose concentrations are increased in IBD (11), stimulate Na ϩ absorption in inflamed tissue by increasing ENaC activity (97) . In addition, intestinal ENaC activity stimulation by aldosterone is reduced or lost in UC and IL-2 Ϫ/Ϫ mice (5, 13). Interestingly, in the human colorectal cancer HT-29/B6-GR cell line, glucocorticoid treatment not only prevented ENaC suppression by TNF-␣ but even induced a synergistic activation of these channels (17) . In summary, ENaC decreased activity contributes to a low IT sodium absorption in IBD and is a consequence of cytokine-driven reduced transcription and cell depolarization secondary to the abovementioned decreased BLM IK channel activity (2) (Fig. 1) .
THERAPEUTIC TARGETS AND FUTURE CHALLENGES
Given the clear involvement of NKA and NHE3 in IBDassociated diarrhea, one could rightfully think of them as potential therapeutic targets. In fact, glucocorticoids, widely used drugs in IBD, increase sodium absorption by activating epithelial NHE3 through genomic (159) and nongenomic SGK (glucocorticoid-induced kinases)-dependent effects (55) . However, NKA's and NHE3's broad tissue distribution and the need for upregulation instead of inhibition are barriers to the design of a specific, low-adverse-effect drug. To our knowledge, there is no direct NKA or NHE3 activator available. Therefore, the focus should probably be on targeting the inflammatory mediators that regulate their expression, as has been successfully done for TNF-␣ (15) and IFN-␥ (33) . A very promising factor is LPA. LPA is known to increase the trafficking of NHE3 to the IEC apical membrane through a pathway that involves the PLA 5 receptor, NHERF2, EGFR, and RSK2, and its oral administration was able to overcome diarrhea induced by cholera toxin or TNF-␣ in mice (86, 105) . The recent synthesis of OTP (octadecenyl thiophosphate), an oral LPA analog with greater resistance to pancreatic lipase and LPP1 and lower systemic absorption than the original molecule, further raises hopes on a new anti-diarrhea drug (37) .
The role of IEC NHE1 in IBD needs further clarification, but from an outcome perspective, amiloride's ability to decrease disease manifestations in TNBS-and DSS-treated rats is interesting, even if this is due to the inhibition intraepithelial leukocytes' NHE (70, 103) .
Glucocorticoids are known to enhance ENaC-mediated sodium absorption (17) . A randomized, double-blind clinical trial suggested that EGF enemas with oral mesalamine are an effective treatment for active left-sided UC (see Epithelial Naϩ Channels' Activity Is Decreased in IBD above for the rationale of this intervention) (130) . Even though the EGFR ligands increase the risk of colorectal cancer (108) , this study further supports the therapeutic potential of upregulating ENaC activity. Therefore, S3969, a novel small molecule activator of ENaC, might be clinically useful (91) .
Lastly, there is a serious lack of knowledge regarding intestinal epithelial K ϩ channels. IK Ϫ/Ϫ mice were protected from developing colitis in two mouse IBD models (38) , and NS6180, a novel IK channel inhibitor, reduced colon inflammation as much as sulfasalazine (132) . However, these results were attributed to the inhibition of lymphocytic, and not IEC, channels. K ATP channels do play a role in IBD since the blocker glibenclamide worsens colitis (35, 42) whereas sildenafil (42), nicorandil (60) and H 2 S (140) have beneficial effects on this condition, but intestinal epithelial K ATP channels need further research before they can be considered therapeutic targets. Finally, it would be of high interest to test IEC BK channel blockers or inhibitors [multiple examples can be found in the review by Nardi and Olesen (101)] in experimental colitis models.
Irrespective of the chosen target, one should remember that cells are highly complex systems that will likely try to compensate any artificial interference [an example being the upregulation of small intestine NHE2 and NHE3 in NHE8 Ϫ/Ϫ mice (153)]. Hence, multiple approaches might need to be taken.
CONCLUSION
NKA activity is decreased in IBD owing to IFN-␥, TNF-␣, IL-1␤, and NO actions. This increases [Na ϩ ] i , which contributes to decreases in NHE3 activity, itself already downregulated by IFN-␥, TNF-␣, NO, activated TLR4, and reduced NHERF. The result is a decrease in sodium absorption. The basolateral NHE1 are also probably decreased in IBD because of the activation of TLRs, which would account for the lower pH in IBD-afflicted colonocytes and further increases [Na ϩ ] i . The basolateral IK channels appear to be downregulated, depolarizing the cell and increasing intracellular K ϩ concentration, which in turns facilitates the outward movement of K ϩ ions through the aldosterone and/or NO-upregulated apical BK channels. This depolarization stacks with IFN-␥ and TNF-␣ actions in the inhibition of ENaC-mediated Na ϩ absorption (which is most important in distal colon). Hence, both lower sodium absorption and increased K ϩ excretion contribute to IBD-associated diarrhea (Fig. 1) . However, clearly much is still to be discovered, in particular about the epithelial potassium channels, and most interactions lack properly known intracellular pathways. Furthermore, both increased anion secretion (stimulated by, for example, NH 2 Cl's effects on ATPase activity and basolateral Ca 2ϩ -dependent K ϩ channels) and barrier disruption need to be taken into account in the complete IBD-associated diarrhea pathophysiological model; thus research is also required in this area. This knowledge will surely allow the development of better treatments to this incapacitating symptom. absorption and altered Na ϩ /H ϩ exchanger 3 (NHE3) activity in NHE regulatory factor 1 (NHERF1) adaptor protein-deficient mice. 
